Literature DB >> 12631453

Intraductal papillary mucinous tumors of the pancreas.

Friedrich H Schmitz-Winnenthal1, Kaspar Z'graggen, Christine Volk, Bruno M Schmied, Markus W Büchler.   

Abstract

Cystic neoplasms of the exocrine pancreas are a small fraction of pancreatic tumors. Within that group of cystic neoplasms, intraductal papillary mucinous tumors (IPMTs) can be distinguished from mucinous cystic neoplasms, serous cystic neoplasms, and pseudopapillary cystic tumors. Awareness of IPMTs has increased since the World Health Organization classified these tumors as its own group in 1996. Because of their favorable prognosis, an extensive diagnostic workup for IPMTs should be performed in patients presenting with cystic lesions of the pancreas. This workup often leads to the diagnosis and the predominant tumor location and size, although the extent of the ductal changes can only be established by histopathology. Surgical resection is the therapy of choice for IPMTs. The type of resection depends upon the extent of the quantitative and qualitative ductal involvement. Total pancreatectomy is currently the treatment for an IPMT that comprises the entire main duct.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631453     DOI: 10.1007/s11894-003-0082-y

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  54 in total

1.  Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Suresh T Chari; Dhiraj Yadav; Thomas C Smyrk; Eugene P DiMagno; Laurence J Miller; Massimo Raimondo; Jonathan E Clain; Ian A Norton; Randall K Pearson; Bret T Petersen; Maurits J Wiersema; Michael B Farnell; Michael G Sarr
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

2.  Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas.

Authors:  E Cuillerier; C Cellier; L Palazzo; J Devière; P Wind; F Rickaert; P H Cugnenc; M Cremer; J P Barbier
Journal:  Am J Gastroenterol       Date:  2000-02       Impact factor: 10.864

3.  Intraductal papillary mucinous tumors of the pancreas.

Authors:  T Nakagohri; T Kenmochi; O Kainuma; Y Tokoro; T Asano
Journal:  Am J Surg       Date:  1999-10       Impact factor: 2.565

4.  The spectrum of mucin-producing adenocarcinoma of the pancreas.

Authors:  E E Whang; T Danial; J C Dunn; S W Ashley; H A Reber; T J Lewin; R K Tompkins
Journal:  Pancreas       Date:  2000-08       Impact factor: 3.327

5.  Surgical treatment of intraductal papillary-mucinous tumors of the pancreas.

Authors:  N Kanazumi; A Nakao; T Kaneko; S Takeda; A Harada; S Inoue; T Nagasaka; N Nakashima
Journal:  Hepatogastroenterology       Date:  2001 Jul-Aug

6.  Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.

Authors:  F Maire; P Hammel; B Terris; F Paye; J-Y Scoazec; C Cellier; M Barthet; D O'Toole; P Rufat; C Partensky; E Cuillerier; P Lévy; J Belghiti; P Ruszniewski
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

7.  Adenocarcinoma of the pancreas with a predominant intraductal component: a special variety of ductal adenocarcinoma.

Authors:  P Stömmer; C Gebhardt; K H Schultheiss
Journal:  Pancreas       Date:  1990       Impact factor: 3.327

8.  Management of intraductal papillary mucinous tumours of the pancreas.

Authors:  F Navarro; J Michel; P Bauret; J Ramos; P Blanc; J M Fabre; B Millat; B Desrousseaux; J Domergue
Journal:  Eur J Surg       Date:  1999-01

9.  Mucin-hypersecreting carcinoma of the pancreas.

Authors:  Y Itai; T Kokubo; Y Atomi; A Kuroda; Y Haraguchi; A Terano
Journal:  Radiology       Date:  1987-10       Impact factor: 11.105

10.  Mucinous ductal ectasia of the pancreas: a premalignant disease and a cause of obstructive pancreatitis.

Authors:  C Bastid; J P Bernard; H Sarles; M J Payan; J Sahel
Journal:  Pancreas       Date:  1991-01       Impact factor: 3.327

View more
  5 in total

1.  Enucleation in pancreatic surgery: indications, technique, and outcome compared to standard pancreatic resections.

Authors:  Thilo Hackert; Ulf Hinz; Stefan Fritz; Oliver Strobel; Lutz Schneider; Werner Hartwig; Markus W Büchler; Jens Werner
Journal:  Langenbecks Arch Surg       Date:  2011-05-08       Impact factor: 3.445

2.  Side-branch intraductal papillary mucinous neoplasms of the pancreatic head/uncinate: resection or enucleation?

Authors:  Olivier Turrini; C Max Schmidt; Henry A Pitt; Jerome Guiramand; Juan R Aguilar-Saavedra; Shadi Aboudi; Keith D Lillemoe; Jean Robert Delpero
Journal:  HPB (Oxford)       Date:  2011-02       Impact factor: 3.647

Review 3.  Morphogenesis of pancreatic cancer: role of pancreatic intraepithelial neoplasia (PanINs).

Authors:  Jan-Bart M Koorstra; Georg Feldmann; Nils Habbe; Anirban Maitra
Journal:  Langenbecks Arch Surg       Date:  2008-02-19       Impact factor: 3.445

4.  Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Norihiro Sato; Noriyoshi Fukushima; Anirban Maitra; Christine A Iacobuzio-Donahue; N Tjarda van Heek; John L Cameron; Charles J Yeo; Ralph H Hruban; Michael Goggins
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

5.  Current knowledge on pancreatic cancer.

Authors:  Juan Iovanna; Maria Cecilia Mallmann; Anthony Gonçalves; Olivier Turrini; Jean-Charles Dagorn
Journal:  Front Oncol       Date:  2012-01-31       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.